Register for OBR daily


To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

CBMG $22.56 3.1600 +16.29%
ADXS $4.27 0.3900 +10.05%
ARWR $15.34 0.7700 +5.28%
ARGS $9.83 0.4400 +4.69%
AMBI $7.92 0.3500 +4.62%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

EXEL $1.85 -2.2900 -55.31%
ZIOP $3.00 -0.2300 -7.12%
IDRA $2.70 -0.1900 -6.57%
ONCY $1.30 -0.0800 -5.80%
Kite $26.82 -1.4500 -5.13%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | Next > | Last >>

Breast Cancer Chemotherapy Varies Widely: Study Raises Questions About Early Treatment Choices

(Forbes) Aug 13, 2014 - Last month, the Journal of Clinical Oncology reported that six chemotherapy regimens commonly given to patients with early-stage breast cancer vary widely in their side effects. The researchers found that some drug combinations are more likely to lead to hospitalization than others.
read article 

Cancer: Unpronounceable Drugs, Incomprehensible Prices

(Forbes) Aug 13, 2014 - Cancer drug prices keep rising. The industry says this reflects the rising costs of drug development and the business risks they must take when testing new drugs. I think they charge what they think they can get away with, which goes up every year.
read article 

Editing HPV's Genes To Kill Cervical Cancer Cells

(Duke Today) Aug 8, 2014 - Researchers have hijacked a defense system normally used by bacteria to fend off viral infections and redirected it against the human papillomavirus (HPV), the virus that causes cervical, head and neck, and other cancers.
read article 

Exclusive: Apple Prepares Healthkit Rollout Amid Tangled Regulatory Web

(Reuters) Aug 12, 2014 - Apple Inc has been discussing how its "HealthKit" service will work with health providers at Mount Sinai, the Cleveland Clinic and Johns Hopkins as well as with Allscripts, a competitor to electronic health records provider Epic Systems, people familiar with the discussions said.
read article 

World Health Organization Endorses Use of Experimental Ebola Drugs

(New York Times) Aug 12, 2014 - The World Health Organization made its decision known as a Spanish priest became the first European known to have died in the Ebola outbreak.
read article 

Gene Linked to Alzheimer’s Found Not Needed by Brain

(Bloomberg) Aug 12, 2014 - Loss of function of the gene in the brain tied to Alzheimer’s disease may not lead to memory and thinking problems, according to a surprise finding that upends some theories about the disease.
read article 

Pfizer, 23andMe Team up to Study Bowel Disease

(ABC News/Associated Press) Aug 12, 2014 - Pfizer Inc. is teaming up with DNA testing company 23andMe to study the possible genetic underpinnings of inflammatory bowel disease, a hard-to-treat ailment that affects an estimated 1.4 million Americans.
read article 

Intercept Shares Surge After Releasing Positive Liver Drug Data

(MarketWatch/Wall Street Journal) Aug 12, 2014 - Intercept Pharmaceuticals Inc. on Monday released additional results of a closely watched clinical trial suggesting that an experimental liver-disease drug may have had a more benign effect on patients’ cholesterol levels than initially thought.
read article 

Cancer Research UK Urges Medical Community to Help Make Wikipedia More Accurate

(Cancer Research UK) Aug 8, 2014 - Cancer Research UK is today (Friday) calling for scientists, doctors and nurses to get more involved in Wikipedia to help ensure the free online encyclopaedia has the most up to date and accurate information on cancer.
read press release 

PSA Test Is Misused, Unreliable, Says the Antigen's Discoverer

(Medscape Medical News) Aug 8, 2014 - Richard J. Ablin, PhD, DSc (Hon), who first discovered prostate-specific antigen (PSA) in 1970, explains why physicians and patients should proceed with caution when using PSA as a marker for preventive screening.
read article (free registration required) 

Tokai, Chasing the Field in Prostate Cancer, Files For IPO

(Xconomy Boston) Aug 12, 2014 - Tokai Pharmaceuticals has been chasing after the big players in the prostate cancer field with the idea of combining some of the best features of their drugs into a single pill. Now, with that lead drug candidate, galeterone, on the precipice of a late-stage trial, it’s taking that pitch to Wall Street.
read article 

Seattle Oncology Company Acquires Alpine Biosciences for $27 Million

(Puget Sound Business Journal/Health Care NW blog) Aug 11, 2014 - Seattle-based oncology company Oncothyreon Inc. has acquired Alpine Biosciences, a biotechnology company developing protocells, a technology platform designed to deliver therapeutic agents.
read article 

Invitae Offers PALB2 Testing, Providing Clinicians with a Reliable, Fast, Affordable Option for Patients

(Yahoo! Finance) Aug 11, 2014 - Invitae Corporation, a genetic information company, offers PALB2 testing, providing clinicians with a reliable, fast and affordable option for their cancer patients. The test is globally available and is priced at $1,500 in the United States.
read article 

Spotting Cancer in a Vial

(MIT Technology Review) Aug 11, 2014 - He watched his brother die from a cancer that no drug could cure. Now one of the world’s most renowned cancer researchers says it’s time for Plan B.
read article 

Seattle Genetics Initiates Phase 1 Clinical Trial of Antibody-Drug Conjugate SGN-CD70A for Non-Hodgkin Lymphoma and Renal Cell Carcinoma

(MarketWatch) Aug 12, 2014 - Seattle Genetics, Inc. today announced the initiation of a phase 1 clinical trial evaluating SGN-CD70A for CD70-positive relapsed or refractory non-Hodgkin lymphoma (NHL) and metastatic renal cell carcinoma (RCC).
read article 

Scripps Research Institute Scientists Demonstrate Long-Sought Drug Candidate Can Halt Tumor Growth

(TSRI) Aug 11, 2014 - It’s a trick any cat burglar knows: to open a locked door, slide a credit card past the latch.
read press release 

ASU-Mayo Researchers Use Calcium Isotope Analysis to Predict Myeloma Progression

(Science Codex) Aug 12, 2014 - A team of researchers from Arizona State University and Mayo Clinic is showing how a staple of Earth science research can be used in biomedical settings to predict the course of disease.
read article 

Researchers Discover a Metabolic Mechanism for Resistant Pancreatic Cancer

(MD Anderson) Aug 11, 2014 - Knock out a genetic mutation that’s a driving force behind pancreatic cancer and a few cells quietly hunker down in the resulting scar tissue, nibbling on themselves to survive before roaring back as resistant disease that taps the cell’s normal powerhouses to thrive.
read press release 

It's Rare, But Yet Another Breast Cancer Gene Identified

(Medscape Medical News) Aug 11, 2014 - Women with a rare gene mutation and associated hereditary endocrine disease are at an increased risk for breast cancer, according to a letter published in the August 7 issue of the New England Journal of Medicine.
read article (free registration required) 

For Older Colon Cancer Survivors, Colonoscopies Carry Risks: Study

(Reuters Health) Aug 12, 2014 - After age 75, recurrences of colon cancer are rare and the risks of repeated colonoscopies may outweigh the benefits, according to new research.
read article 

Bone Drugs May Not Protect Osteoporotic Women from Breast Cancer

(UCSF) Aug 11, 2014 - Osteoporosis drugs known as bisphosphonates may not protect women from breast cancer as had been thought, according to a new study led by researchers at UC San Francisco.
read article 

Screening Test For Colon Cancer Wins FDA Approval

(Kaiser Health News) Aug 12, 2014 - The test, called Cologuard, can detect genetic mutations in patients' stool samples that are associated with cancerous and precancerous growths.
read article 

FDA Approves First Non-invasive DNA Screening Test for Colorectal Cancer

( Aug 11, 2014 - The U.S. Food and Drug Administration today approved Cologuard, the first stool-based colorectal screening test that detects the presence of red blood cells and DNA mutations that may indicate the presence of certain kinds of abnormal growths that may be cancers such as colon cancer or precursors to cancer.
read press release 

Halaven Fails to Meet Primary Endpoint in NSCLC

(Healio) Aug 8, 2014 - Results from a phase 3 trial have found that eribulin did not meet its primary endpoint of OS for the treatment of non-small cell lung cancer that has progressed following two or more prior treatment regimens, the manufacturer announced today.
read article 

U.S. Lung Cancer Rates Falling Overall, Study Finds

( News) Aug 11, 2014 - Overall lung cancer rates are dropping, according to a new analysis of nearly a half million Americans with lung cancer. But, the news wasn't all good -- the study also found that the rates of certain types of lung cancer are increasing, according to researchers from the U.S. National Cancer Institute (NCI).
read article